Amund Gulsvik

19.7k total citations · 3 hit papers
218 papers, 10.5k citations indexed

About

Amund Gulsvik is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Amund Gulsvik has authored 218 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pulmonary and Respiratory Medicine, 95 papers in Physiology and 24 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Amund Gulsvik's work include Chronic Obstructive Pulmonary Disease (COPD) Research (117 papers), Asthma and respiratory diseases (88 papers) and Respiratory Support and Mechanisms (39 papers). Amund Gulsvik is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (117 papers), Asthma and respiratory diseases (88 papers) and Respiratory Support and Mechanisms (39 papers). Amund Gulsvik collaborates with scholars based in Norway, United States and United Kingdom. Amund Gulsvik's co-authors include Per Bakke, Geir Egil Eide, Ernst Omenaas, Tomas Eagan, A. Sonia Buist, Ane Johannessen, William M. Vollmer, Rolf Hanoa, Peter Burney and Sean D. Sullivan and has published in prestigious journals such as The Lancet, Bioinformatics and PLoS ONE.

In The Last Decade

Amund Gulsvik

211 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study

2007 1.6k citations A. Sonia Buist, Sean D. Sullivan et al. profile →
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

2003 894 citations Amund Gulsvik et al. profile →
A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

2009 480 citations Sreekumar Pillai, Guohua Zhu et al. profile →

Peers

Countries citing papers authored by Amund Gulsvik

Since Specialization

Citations

This map shows the geographic impact of Amund Gulsvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amund Gulsvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amund Gulsvik more than expected).

Fields of papers citing papers by Amund Gulsvik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amund Gulsvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amund Gulsvik. The network helps show where Amund Gulsvik may publish in the future.

Co-authorship network of co-authors of Amund Gulsvik

This figure shows the co-authorship network connecting the top 25 collaborators of Amund Gulsvik. A scholar is included among the top collaborators of Amund Gulsvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amund Gulsvik. Amund Gulsvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes 2015 ·American Journal of Respiratory and Critical Care Medicine ·Michael H. Cho, Peter J. Castaldi, Craig P. Hersh, Brian D. Hobbs, R. Graham Barr, Ruth Tal‐Singer, Per Bakke, Amund Gulsvik, Raúl San Jośe Estépar, Edwin J.R. van Beek, Harvey O. Coxson, David A. Lynch, George R. Washko, Nan M. Laird, James D. Crapo, Terri H. Beaty, Edwin K. Silverman	97
2	Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization 2013 ·European Respiratory Journal ·Ane Johannessen, Roy M. Nilsen, (unknown), Amund Gulsvik, Tomas Eagan, Per Bakke	5
3	The Association of Genome-Wide Significant Spirometric Loci with Chronic Obstructive Pulmonary Disease Susceptibility 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Peter J. Castaldi, Michael H. Cho, Augusto A. Litonjua, Per Bakke, Amund Gulsvik, David A. Lomas, W. J. Anderson, Terri H. Beaty, John E. Hokanson, James D. Crapo, Nan M. Laird, Edwin K. Silverman	66
4	Socioeconomic risk factors for lung function decline in a general population 2010 ·European Respiratory Journal ·Ane Johannessen, Tomas Eagan, Ernst Omenaas, Per Bakke, Amund Gulsvik	30
5	Body mass index, weight gain, and other determinants of lung function decline in adult asthma 2009 ·Journal of Allergy and Clinical Immunology ·Alessandro Marcon, Angelo Guido Corsico, Lucia Cazzoletti, Massimiliano Bugiani, Simone Accordini, E. Almar, Isa Cerveri, Davíð Gíslason, Amund Gulsvik, Christer Janson, Deborah Jarvis, Jesús Martínez-Moratalla, Isabelle Pin, Roberto de Marco	31
6	CTLA4gene polymorphisms are associated with chronic bronchitis 2009 ·European Respiratory Journal ·Guohua Zhu, Àlvar Agustí, Amund Gulsvik, P Bakke, (unknown), DA Lomas, Edward Silverman, (unknown)	22
7	Occupational exposure and incidence of respiratory disorders in a general population 2009 ·Scandinavian Journal of Work Environment & Health ·Trude Duelien Skorge, Tomas Eagan, Geir Egil Eide, Amund Gulsvik, Per Bakke	23
8	Present and future costs of COPD in Iceland and Norway: results from the BOLD study 2009 ·European Respiratory Journal ·(unknown), Ane Johannessen, Bryndís Benediktsdóttir, Þórarinn Gíslason, A. Sonia Buist, Amund Gulsvik, Sean D. Sullivan, Todd A. Lee	64
9	Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking 2009 ·European Respiratory Journal ·Thomas Blix Grydeland, Asger Dirksen, Harvey O. Coxson, Sreekumar Pillai, Sanjay Sharma, Geir Egil Eide, Amund Gulsvik, Per Bakke	153
10	Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE 2007 ·Journal of Allergy and Clinical Immunology ·Roberto de Marco, Alessandro Marcon, Deborah Jarvis, Simone Accordini, Massimiliano Bugiani, Lucia Cazzoletti, Isa Cerveri, Angelo Guido Corsico, Davíð Gíslason, Amund Gulsvik, Rain Jögi, Jesús Martínez-Moratalla, Isabelle Pin, Christer Janson	42
11	The Adult Incidence of Asthma and Respiratory Symptoms by Passive Smoking In Utero or in Childhood 2005 ·American Journal of Respiratory and Critical Care Medicine ·Trude Duelien Skorge, Tomas Eagan, Geir Egil Eide, Amund Gulsvik, Per Bakke	88
12	Occupational Airborne Exposure and the Incidence of Respiratory Symptoms and Asthma 2002 ·American Journal of Respiratory and Critical Care Medicine ·Tomas Eagan, Amund Gulsvik, Geir Egil Eide, Per Bakke	72
13	Bronchitic symptoms and their reltion to FEV1 in Italy, Sweden and Norway 2001 ·European Respiratory Review ·Bo Lundbäck, Laura Carrozzi, Per Bakke, Eva Rönmark, Francesco Di Pede, (unknown), Giovanni Viegi, Amund Gulsvik, Carlo Giuntini	2
14	FEV6 As a Surrogate for FVC: Authors Should have Included ROC-Curve Analyses 2001 ·American Journal of Respiratory and Critical Care Medicine ·Jan Brøgger, Geir Egil Eide, Amund Gulsvik	3
15	Applicability of the Single-Breath Carbon Monoxide Diffusing Capacity in a Norwegian Community Study 1998 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Geir Egil Eide, Per Bakke, Amund Gulsvik	19
16	Forced expiratory volume in 1 second (FEV₁) and forced vital capacity (FVC) variability in asymptomatic never‐smoking men 1998 ·Clinical Physiology ·Sjur Humerfelt, Geir Egil Eide, Gunnar Kvåle, Amund Gulsvik	13
17	Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community 1996 ·European Respiratory Journal ·Ernst Omenaas, Per Bakke, GE Eide, S. Elsayed, Amund Gulsvik	31
18	Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community 1993 ·European Respiratory Journal ·Sjur Humerfelt, Amund Gulsvik, Rolv Skjærven, Steinar Nilssen, Gunnar Kvåle, (unknown), (unknown), (unknown)	63
19	Smoking and giving of patient information by chest physicians. 1986 ·PubMed ·Tor Aasen, Amund Gulsvik	3
20	Cardiac arrhythmias in patients with serious pulmonary diseases. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Amund Gulsvik, (unknown), E Sivertssen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact